Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion type Assertion NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_head.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_provenance.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion evidence source_evidence_literature NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_provenance.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion SIO_000772 14628083 NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_provenance.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion wasDerivedFrom befree-20150227 NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_provenance.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion wasGeneratedBy ECO_0000203 NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_provenance.